Navamedic approves capital raise of up to NOK 130m

Navamedic ASA shareholders approved a capital increase through a rights issue ranging from NOK 81.5m to NOK 130m by issuing 5.1 to 6.0 million new shares at NOK 21.50 per share.

The subscription period runs from September 22 to October 6, 2025, with shareholders on record as of July 14 having preferential rights.

The board also received authorization to increase share capital by up to NOK 4.3m through additional share issuances until December 31, 2025. Total costs for the capital increase are estimated at NOK 11.5m to NOK 14.5m.